Esperion Therapeutics
ESPR
#6188
Rank
$0.87 B
Marketcap
$3.70
Share price
-0.40%
Change (1 day)
58.58%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2025 (TTM): -$0.50

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.50. In 2024 the company made an earnings per share (EPS) of -$0.23 an increase over its 2023 EPS that were of -$2.12.

EPS history for Esperion Therapeutics from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-$0.50117.39%
2024-$0.23-89.15%
2023-$2.12-40.28%
2022-$3.55-62.87%
2021-$9.5680.38%
2020-$5.3050.14%
2019-$3.53-53.18%
2018-$7.547.41%
2017-$7.02110.81%
2016-$3.3347.35%
2015-$2.260.89%
2014-$2.24

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ultragenyx Pharmaceutical
RARE
-$5.94 1,088.00%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
$2.72-644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$1.72-444.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
$43.44-8,788.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
-$0.11-78.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-$0.19-62.00%๐Ÿ‡บ๐Ÿ‡ธ USA